The exosomal transfer of human bone marrow mesenchymal stem cell-derived miR-1913 inhibits osteosarcoma progression by targeting NRSN2
CONCLUSION: The inhibitory role of hBMSC-derived miR-1913 on osteosarcoma progression was achieved by targeting NRSN2, indicating the potential therapeutic value of hBMSC-derived miR-1913.PMID:34650689 | PMC:PMC8507079
Source: Cell Research - Category: Cytology Authors: Jihui Zhou Lili Xu Peng Yang Yao Lu Shibang Lin Guanghai Yuan Source Type: research
More News: Bone Cancers | Cancer & Oncology | Cytology | Osteosarcoma | Stem Cell Therapy | Stem Cells | Study